Treatment-related biomarkers in pulmonary hypertension patients on oral therapies

BACKGROUND: Multiple classes of oral therapy are available for the treatment of pulmonary arterial hypertension (PAH), but there is little to guide clinicians in choosing a specific regimen or therapeutic class. We aimed to investigate whether treatment-relevant blood biomarkers can predict therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaminathan, Aparna C., Zhu, Hongmei, Tapson, Victor, Lokhnygina, Yuliya, Poms, Abby, Kelleher, Zach, Gaspard, Elijah, Kennedy, Karla, Fee, Brian E., Fortin, Terry, Mason, S. Nicholas, Parikh, Kishan, McMahon, Tim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678114/
https://www.ncbi.nlm.nih.gov/pubmed/33213478
http://dx.doi.org/10.1186/s12931-020-01566-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678114/
https://www.ncbi.nlm.nih.gov/pubmed/33213478
http://dx.doi.org/10.1186/s12931-020-01566-y

Ejemplares similares